Cargando…

Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?

Drug induced liver injury (DILI) is a potentially serious adverse reaction in a few susceptible individuals under therapy by various drugs. Health care professionals facing DILI are confronted with a wealth of drug-unrelated liver diseases with high incidence and prevalence rates, which can confound...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teschke, Rolf, Schulze, Johannes, Eickhoff, Axel, Danan, Gaby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412387/ https://www.ncbi.nlm.nih.gov/pubmed/28398242 http://dx.doi.org/10.3390/ijms18040803

Ejemplares similares

RUCAM in Drug and Herb Induced Liver Injury: The Update
por: Danan, Gaby, et al.
Publicado: (2015)

Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
por: Teschke, Rolf, et al.
Publicado: (2021)

Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis
por: Teschke, Rolf, et al.
Publicado: (2020)

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method
por: Teschke, Rolf, et al.
Publicado: (2022)

Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
por: Danan, Gaby, et al.
Publicado: (2019)

Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs
por: Teschke, Rolf, et al.
Publicado: (2016)

Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?
por: Teschke, Rolf, et al.
Publicado: (2013)

Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use
por: Teschke, Rolf, et al.
Publicado: (2023)

Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases
por: Teschke, Rolf, et al.
Publicado: (2020)

Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?
por: Teschke, Rolf, et al.
Publicado: (2018)

Molecular Research on Drug Induced Liver Injury
por: Teschke, Rolf, et al.
Publicado: (2018)

Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
por: Teschke, Rolf
Publicado: (2019)

Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies
por: Teschke, Rolf, et al.
Publicado: (2021)

Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support
por: Teschke, Rolf, et al.
Publicado: (2019)

The LiverTox Paradox-Gaps between Promised Data and Reality Check
por: Teschke, Rolf, et al.
Publicado: (2021)

Circulatory Inflammatory Mediators in the Prediction of Anti-Tuberculous Drug-Induced Liver Injury Using RUCAM for Causality Assessment
por: Ho, Cheng-Maw, et al.
Publicado: (2021)

Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause
por: Bokan, Goran, et al.
Publicado: (2023)

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China
por: Chen, Yongwu, et al.
Publicado: (2021)

Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic Leukemia as Assessed for Causality Using the Updated RUCAM
por: Qin, Fu-Li, et al.
Publicado: (2022)

Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature
por: Xia, Caixia, et al.
Publicado: (2020)

Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAM
por: Tzadok, Roie, et al.
Publicado: (2022)

A Case of Delayed Hepatic Injury Associated with Teriflunomide Use as Assessed for Causality Using the Updated RUCAM
por: Wurzburger, Riana
Publicado: (2022)

A case report of a drug‐induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing
por: González‐Muñoz, Miguel, et al.
Publicado: (2020)

Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
por: Ahmadi, Ali R., et al.
Publicado: (2020)

The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges
por: Teschke, Rolf, et al.
Publicado: (2016)

Urine metabolomics and microbiome analyses reveal the mechanism of anti-tuberculosis drug-induced liver injury, as assessed for causality using the updated RUCAM: A prospective study
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM
por: Andújar-Vera, Francisco, et al.
Publicado: (2023)

Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM
por: Zheng, Caiyun, et al.
Publicado: (2023)

A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System
por: Mascherona, Ilenia, et al.
Publicado: (2020)

A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale
por: Shi, Xiaoping, et al.
Publicado: (2022)

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
por: Yang, Hongyi, et al.
Publicado: (2019)

Curcuma longa Hepatotoxicity: A Baseless Accusation. Cases Assessed for Causality Using RUCAM Method
por: Stati, Gianmarco, et al.
Publicado: (2021)

Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature
por: Abeles, Robin Daniel, et al.
Publicado: (2020)

Treatment of Drug-Induced Liver Injury
por: Teschke, Rolf
Publicado: (2022)

Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM
por: Plüß, Marlene, et al.
Publicado: (2022)

Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury
por: Jing, Jing, et al.
Publicado: (2017)

Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps
por: Teschke, Rolf, et al.
Publicado: (2015)

Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature
por: Studentova, Hana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8n0g41i0ubuvsn09hv1b1dmvhn